Literature DB >> 17548629

RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells.

Yi-Ping Jin1, Yael Korin, Xiaohai Zhang, Peter T Jindra, Enrique Rozengurt, Elaine F Reed.   

Abstract

Ligation of class I molecules by anti-HLA Ab stimulates an intracellular signaling cascade resulting in endothelial cell (EC) survival and proliferation, and has been implicated in the process of chronic allograft rejection and transplant-associated vasculopathy. In this study, we used small interfering RNA blockade of focal adhesion kinase (FAK) protein to determine its role in class I-mediated organization of the actin cytoskeleton, cell survival, and cell proliferation in primary cultures of human aortic EC. Knockdown of FAK appreciably inhibited class I-mediated phosphorylation of Src at Tyr(418), p85 PI3K, and Akt at both Thr(308) and Ser(473) sites. FAK knockdown also reduced class I-mediated phosphorylation of paxillin at Try(118) and blocked class I-induced paxillin assembly into focal contacts. FAK small interfering RNA completely abrogated class I-mediated formation of actin stress fibers. Interestingly, FAK knockdown did not modify fibroblast growth factor receptor expression induced by class I ligation. However, FAK knockdown blocked HLA class I-stimulated cell cycle proliferation in the presence and absence of basic fibroblast growth factor. This study shows that FAK plays a critical role in class I-induced cell proliferation, cell survival, and focal adhesion assembly in EC and may promote the development of transplant-associated vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548629     DOI: 10.4049/jimmunol.178.12.7911

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Antibody-induced vascular inflammation skews infiltrating macrophages to a novel remodeling phenotype in a model of transplant rejection.

Authors:  Xuedong Wei; Nicole M Valenzuela; Maura Rossetti; Rebecca A Sosa; Jessica Nevarez-Mejia; Gregory A Fishbein; Arend Mulder; Jayeeta Dhar; Karen S Keslar; William M Baldwin; Robert L Fairchild; Jianquan Hou; Elaine F Reed
Journal:  Am J Transplant       Date:  2020-05-22       Impact factor: 8.086

2.  Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner.

Authors:  Fang Li; Xiaohai Zhang; Yi-Ping Jin; Arend Mulder; Elaine F Reed
Journal:  Hum Immunol       Date:  2011-10-01       Impact factor: 2.850

3.  HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration.

Authors:  Xiaohai Zhang; Enrique Rozengurt; Elaine F Reed
Journal:  Sci Signal       Date:  2010-11-23       Impact factor: 8.192

4.  Prediction of sphingosine 1-phosphate-stimulated endothelial cell migration rates using biochemical measurements.

Authors:  Shannon K Alford; Yumei Wang; Yunfeng Feng; Gregory D Longmore; Donald L Elbert
Journal:  Ann Biomed Eng       Date:  2010-04-01       Impact factor: 3.934

Review 5.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

6.  Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis.

Authors:  Ingrid Fert; Nicolas Cagnard; Simon Glatigny; Franck Letourneur; Sébastien Jacques; Judith A Smith; Robert A Colbert; Joel D Taurog; Gilles Chiocchia; Luiza M Araujo; Maxime Breban
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

7.  Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.

Authors:  N M Valenzuela; L Hong; X-Da Shen; F Gao; S H Young; E Rozengurt; J W Kupiec-Weglinski; M C Fishbein; E F Reed
Journal:  Am J Transplant       Date:  2012-12-27       Impact factor: 8.086

8.  Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.

Authors:  Y-P Jin; N M Valenzuela; M E Ziegler; E Rozengurt; E F Reed
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

Review 9.  Effect of antibodies on endothelium.

Authors:  X Zhang; E F Reed
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

10.  Report from a consensus conference on the sensitized patient awaiting heart transplantation.

Authors:  Jon Kobashigawa; Mandeep Mehra; Lori West; Ronald Kerman; James George; Marlene Rose; Adriana Zeevi; Nancy Reinsmoen; Jignesh Patel; Elaine F Reed
Journal:  J Heart Lung Transplant       Date:  2009-03       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.